EarningsQ2 2024 Earnings Report

Nektar Therapeutics (NKTR) Q2 2024 Earnings Report

0 Followers

MX:NKTR Q2 2024 EPS Results

Actual EPS-$68.11

Consensus EPS-$50.40

Beat/MissMissed by -$17.71

One Year Ago EPS-$73.55

Actual Revenue$426.59M

Expected Revenue$330.61M

Beat/MissBeat by +$95.98M

YoY Revenue Growth+14.59%

QuarterQ2 2024

Date08/08/2024

TimeAfter Close

Conference CallThursday, August 8, 2024

MX:NKTR Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NKTR Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-38.12 / -	-33.962	―
Aug 13, 2026	2026 (Q2)	-35.80 / -22.34	-53.576	58.31% (+31.24)
May 07, 2026	2026 (Q1)	-28.73 / -33.05	-65.381	49.44% (+32.33)
Mar 12, 2026	2025 (Q4)	-44.93 / -32.33	8.173	-495.56% (-40.50)
Nov 06, 2025	2025 (Q3)	-48.76 / -33.96	-49.036	30.74% (+15.07)
Aug 07, 2025	2025 (Q2)	-54.99 / -53.58	-68.105	21.33% (+14.53)
May 08, 2025	2025 (Q1)	-46.57 / -65.38	-51.76	-26.32% (-13.62)
Mar 12, 2025	2024 (Q4)	-36.94 / 8.17	-59.932	113.64% (+68.11)
Nov 07, 2024	2024 (Q3)	-54.21 / -49.04	-65.381	25.00% (+16.35)
Aug 08, 2024	2024 (Q2)	-50.40 / -68.11	-73.553	7.41% (+5.45)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed